J2KBIO Co., Ltd.
J2KBIO Co., Ltd., a bio venture company, offers active ingredients for cosmetics, functional food, and household products from natural materials and microbial fermentation. The company was founded in 2014 and is based in Cheongju, South Korea.
Market Cap & Net Worth: J2KBIO Co., Ltd. (420570)
J2KBIO Co., Ltd. (KQ:420570) has a market capitalization of $30.91 Million (₩45.26 Billion) as of March 19, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #27824 globally and #1848 in its home market, demonstrating a 5.31% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying J2KBIO Co., Ltd.'s stock price ₩7740.00 by its total outstanding shares 5847483 (5.85 Million).
J2KBIO Co., Ltd. Market Cap History: 2024 to 2026
J2KBIO Co., Ltd.'s market capitalization history from 2024 to 2026. Data shows change from $36.34 Million to $30.91 Million (-45.80% CAGR).
J2KBIO Co., Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how J2KBIO Co., Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
J2KBIO Co., Ltd.'s market cap is 0.00 times its annual revenue
0.59x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $36.34 Million | $33.13 Billion | -$1.65 Billion | 0.00x | N/A |
Competitor Companies of 420570 by Market Capitalization
Companies near J2KBIO Co., Ltd. in the global market cap rankings as of March 19, 2026.
Key companies related to J2KBIO Co., Ltd. by market ranking:
- Linde plc Ordinary Shares (NASDAQ:LIN): Ranked #71 globally with a market cap of $210.18 Billion USD.
- L'Air Liquide S.A (PINK:AIQUF): Ranked #182 globally with a market cap of $107.70 Billion USD.
- Air Liquide SA (PA:AI): Ranked #200 globally with a market cap of $99.38 Billion USD ( €96.82 Billion EUR).
- Ecolab Inc (NYSE:ECL): Ranked #266 globally with a market cap of $77.81 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #71 | Linde plc Ordinary Shares | NASDAQ:LIN | $210.18 Billion | $494.05 |
| #182 | L'Air Liquide S.A | PINK:AIQUF | $107.70 Billion | $187.03 |
| #200 | Air Liquide SA | PA:AI | $99.38 Billion | €172.22 |
| #266 | Ecolab Inc | NYSE:ECL | $77.81 Billion | $272.59 |
J2KBIO Co., Ltd. Historical Marketcap From 2024 to 2026
Between 2024 and today, J2KBIO Co., Ltd.'s market cap moved from $36.34 Million to $ 30.91 Million, with a yearly change of -45.80%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩30.91 Million | -10.00% |
| 2025 | ₩34.35 Million | -5.49% |
| 2024 | ₩36.34 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of J2KBIO Co., Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $30.91 Million USD |
| MoneyControl | $30.91 Million USD |
| MarketWatch | $30.91 Million USD |
| marketcap.company | $30.91 Million USD |
| Reuters | $30.91 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.